Enzolytics Inc.

OTC: ENZC · Healthcare · Biotechnology

PublicHQ Plano, TX · CollinCIK 0001421851Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 36

v0.1 · 5/100 weight · pillars only

↑ listing tenure, Altman-Z · ↓ workforce scale, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

—

Employees

Market cap

$3.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Enzolytics Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

ENDRA Life Sciences Inc.26D NuGen Medical Devices Inc.24D Avricore Health Inc.——Matinas BioPharma Holdings, Inc.32D

Neighbors

Collin →

Keurig Dr Pepper Inc.$16.6B80B+Globe Life Inc.$6.0B78B+Tyler Technologies, Inc.$2.3B82B+Diodes Incorporated$1.5B75B+Comstock Resources, Inc.$2.2B75B+Cinemark Holdings, Inc.$3.1B77B+

Key facts

CEOSteven Sharabura

SectorHealthcare

IndustryBiotechnology

HeadquartersPlano, TX

ExchangeOTC: ENZC

Employees1

IPO date2009-04-08

Latest filings

8-K2020-04-16 8-K2019-08-13 10-Q2017-09-15 10-Q2011-05-23 10-K2011-05-19 8-K2011-05-17 8-K2011-05-17 8-K2011-04-05

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.